Performance analysis of Design Therapeutics (DSGN)
Annual Return
Over the past 3 years, DSGN has had an average annual return of +17.32%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, DSGN has had an average annual return of -7.64%, underperforming the benchmark SPY, which returned +12.55% annual.
Since Mar 26, 2021, DSGN has had an average annual return of -20.96%, underperforming the benchmark SPY, which returned +14.04% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +26.54% | +52.05% | +132.71% | -74.16% | -52.07% | -48.40% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +8.85% | +2.23% | +1.91% | +27.85% | -22.94% | +38.08% | -17.98% | +26.54% | |||||
| 2025 | -21.39% | +0.17% | -20.58% | +25.91% | -23.23% | -9.68% | +14.90% | +42.87% | +36.16% | -11.02% | +40.12% | -0.09% | +52.05% |
| 2024 | -10.64% | +17.34% | +44.93% | -12.67% | +15.09% | -17.32% | +52.29% | -6.83% | +13.28% | -2.62% | +14.49% | +2.84% | +132.71% |
| 2023 | -23.49% | -9.94% | -18.37% | +11.79% | -12.73% | +11.86% | +29.25% | -69.52% | -4.85% | -13.53% | +17.48% | +10.55% | -74.16% |
| 2022 | -40.95% | +7.35% | +19.02% | -26.07% | +4.52% | +12.17% | +40.16% | +3.26% | -17.47% | -6.58% | -10.39% | -26.70% | -52.07% |
| 2021 | -27.93% | -12.28% | -0.11% | -24.09% | -22.17% | +1.55% | -6.55% | +6.72% | +6.77% | +27.88% | -48.40% |
Drawdown analysis of Design Therapeutics (DSGN)
The maximum drawdown for the DSGN was -95.20%, occurring on Nov 9, 2023. This drawdown has not yet recovered.
The current DSGN drawdown is -71.39%.
Since Mar 26, 2021 DSGN has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.20% | Mar 26, 2021 | 661 | Nov 9, 2023 | Ongoing | Ongoing | Ongoing |